Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents
ConclusionsHAPR was infrequently present in a large registry of patients undergoing PCI. There was no clear relationship between HAPR and 2-year clinical outcomes. Investigation of antiplatelet regimens without aspirin after DES implantation are ongoing and should inform future management of patients undergoing PCI.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Anatomy | Angioplasty | Aspirin | Bleeding | Cardiology | Clopidogrel | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Thrombosis